New Promise Neuropathy is a burgeoning healthcare institution founded in 2018 in the United States. Specializing in holistic care for peripheral neuropathy, the company has garnered attention with its commitment to transformative patient care. The recent Private Equity Round investment at 27 September 2022 has attracted major investors like Baymark Partners and HCAP Partners, signifying a strong market interest in the company's vision. As a leader in the Health Care industry, New Promise Neuropathy continues to make strides in addressing the pressing medical need for specialized care, positioning itself as a promising investment opportunity for venture capitalists.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 2 | Baymark Partners, HCAP Partners | 27 Sep 2022 |
No recent news or press coverage available for New Promise Neuropathy.
We care about your data, and we'd love to use cookies make your experience better.
